CClinicalTrials.gg
CompletedNCT03736694Updated Mar 25, 2020

Low-intensity Cognitive-behavioural Therapy for Insomnia

An interventional study of Cognitive behavioural therapy for insomnia and Sleep hygiene education in Insomnia, sponsored by The University of Hong Kong. Completed at 1 site in Hong Kong. Open to participants aged 16 Years and older. Per ClinicalTrials.gov, last updated 2020-03-25.

Sponsored by The University of Hong Kong · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
210
Allocation
Randomized
Ages
16 Years and older
Sex
All
01

Study summary

A randomized controlled trial is proposed to compare the effectiveness of workshop-based and self-Help cognitive behavioral therapy for insomnia (CBTI), and sleep hygiene education (SHE) to treat insomnia in Hong Kong adolescent and adult patients, in terms of alleviation of insomnia severity, reduction in associated insomnia symptoms/ complications, and enhancement in quality of life. Insomnia is prevalent in Hong Kong and can cause severe impacts on patients and society, but there is a dearth of related research in the local population. Therefore, it is significant to conduct this study. A total of 210 participants aged > 18 with insomnia will be recruited and randomized into 3 groups to receive one of the 3 treatments. Outcomes will be measured using relevant questionnaires filled in at the baseline, 6 and 12 weeks afterwards. The results obtained will be compared within each group and among the 3 groups using statistical testing to determine the most effective treatment option for insomnia.

02

Conditions studied

  • Insomnia

Keywords

  • Insomnia
  • Cognitive behavioural therapy for insomnia
  • Sleep hygiene education
03

In context

Sleep Initiation and Maintenance Disorders

1,856 studies on the registry are indexed under Sleep Initiation and Maintenance Disorders; 594 are open to participants now.

This study's enrollment of 210 is above the median of 73 across 1,631 interventional studies indexed under Sleep Initiation and Maintenance Disorders.

Browse Sleep Initiation and Maintenance Disorders studies →

Lead sponsor

The University of Hong Kong is the lead sponsor of 1,262 studies on the registry; 340 are open to participants now.

Of its 8 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
16 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Hong Kong residents
  • Aged 16 or above
  • Satisfy the DSM-5 criteria for insomnia, i.e. inability to fall or keep asleep, or wake up too early for 3 days or more per week, throughout a minimum period of 1 month (instead of 3 months in the diagnostic criteria D) using the Brief Insomnia Questionnaire. This is to include episodic insomnia which is considered as an 'other specified insomnia disorder' in DSM-5.
  • Score at least 10 points in Insomnia Severity Index
  • Able to read and understand Cantonese
  • Have Internet access

Exclusion criteria

Exclusion Criteria:

  • Suffer from recently diagnosed and untreated medical, psychiatric or sleep disorders that likely contribute to the onset and maintenance of insomnia, e.g. major depressive disorder, obstructive sleep apnea, restless legs syndrome, chronic pain.
  • Currently receiving CBTI or SHE
  • Work on irregular rotational shift
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
210 participants (actual)

Study arms

  • Experimental
    CBTI Workshop

    The first intervention group (Group 1) will attend one half-day CBTI workshop in the community setting. The workshop is subdivided into 4 sessions, covering topics regarding regulation of stimuli, limit of sleeping duration, relaxation, sleep hygiene and alteration of cognitive beliefs (Arnedt, Cuddihy, \& Swanson, et al, 2014; Morin, Savard, Ouellet, \& Daley, 2003). One workshop has the capacity of 30 participants.

    Behavioral: Cognitive behavioural therapy for insomnia

  • Experimental
    Self-Help CBTI

    The second intervention group (Group 2) will receive self-help CBTI. A CBTI webpage will be set up and the subjects are asked to review all the materials in it. The content is the same as that in Group 1.

    Behavioral: Cognitive behavioural therapy for insomnia

  • Active comparator
    SHE Workshop

    The control group (Group 3) will receive SHE. To ensure uniformity of the therapy model, the participants will also need to attend one half-day face-to-face session, covering topics related to sleep hygiene only. The capacity is also 30 participants.

    Behavioral: Sleep hygiene education

Interventions

  • BehavioralCognitive behavioural therapy for insomnia

    CBTI involves habitual, belief and attitude alterations so as to eliminate factors preventing sleep (Morin, Savard, Ouellet, \& Daley, 2003). It is recommended by the American College of Physicians as the first-line therapy for insomnia (Qaseem, Kansagara, Forciea, Cooke, \& Denberg, 2016). CBTI workshops are a relatively novel and emerging way of delivery which involves a greater number of patients than group CBTI, increases availability and accessibility by concentrating the content into half or whole day and taking place in the community settings, and reduces diagnostic labeling and cost (Bonin, Beecham, Swift, Raikundalia, \& Brown, 2014; Swift, Stewart, Andiappan, Smith, Espie, \& Brown, 2012). Self-help CBTI involves independent learning of the provided materials via the Internet, video or audio recording, books and pamphlets (Bruin, Bogels, Oort, \& Meijer, 2015).

  • BehavioralSleep hygiene education

    SHE, is commonly provided verbally or through leaflets during consultations (Espie, 2009), and is also included as a part of CBTI (Morin, Savard, Ouellet, \& Daley, 2003).

06

What researchers measure

Primary outcomes

  1. Change in Insomnia severity

    To identify whether CBTI workshop, self-help CBTI or SHE workshop results in the greatest alleviation of insomnia severity using the Insomnia Severity Index, which allows the patients to rate their perceived severity and satisfaction level towards their current conditions (Arnedt, Cuddihy \& Swanson, et al, 2014; Wong, Zhang \& Li, et al, 2017).

    Time frame: Baseline assessment (Week 0); Short-term follow-up (Week 8); Long-term follow-up (Week 16)

Secondary outcomes

  1. Change in Symptoms of Mood disorders

    To identify which of the 3 therapies brings the largest reduction mood disorders through the Hospital Anxiety and Depression Scale.

    Time frame: Baseline assessment (Week 0); Short-term follow-up (Week 8); Long-term follow-up (Week 16)

  2. Change in Quality of life

    To investigate which of the 3 therapies improves the quality of life of patients to the greatest extent using the Short-Form Six-Dimension Health Survey.

    Time frame: Baseline assessment (Week 0); Short-term follow-up (Week 8); Long-term follow-up (Week 16)

07

Study locations

1 site
  • The University of Hong Kong
    Hong Kong, Hong Kong
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 25, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03736694
Lead sponsor
The University of Hong Kong
Responsible party
Dr. Chung Ka-Fai (Clinical Associate Professor, The University of Hong Kong) — Principal investigator
First posted
Nov 9, 2018
Start date
Sep 1, 2018
Primary completion
Jun 30, 2019
Completion
Jul 31, 2019
Last update
Mar 25, 2020

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion